TY - JOUR
T1 - Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
AU - Davidson, Shawn M.
AU - Jonas, Oliver
AU - Keibler, Mark A.
AU - Hou, Han Wei
AU - Luengo, Alba
AU - Mayers, Jared R.
AU - Wyckoff, Jeffrey
AU - Del Rosario, Amanda M.
AU - Whitman, Matthew
AU - Chin, Christopher R.
AU - Condon, Kendall J.
AU - Lammers, Alex
AU - Kellersberger, Katherine A.
AU - Stall, Brian K.
AU - Stephanopoulos, Gregory
AU - Bar-Sagi, Dafna
AU - Han, Jongyoon
AU - Rabinowitz, Joshua D.
AU - Cima, Michael J.
AU - Langer, Robert
AU - Vander Heiden, Matthew G.
N1 - Publisher Copyright:
© 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Mammalian tissues rely on a variety of nutrients to support their physiological functions. It is known that altered metabolism is involved in the pathogenesis of cancer, but which nutrients support the inappropriate growth of intact malignant tumors is incompletely understood. Amino acids are essential nutrients for many cancer cells that can be obtained through the scavenging and catabolism of extracellular protein via macropinocytosis. In particular, macropinocytosis can be a nutrient source for pancreatic cancer cells, but it is not fully understood how the tumor environment influences metabolic phenotypes and whether macropinocytosis supports the maintenance of amino acid levels within pancreatic tumors. Here we utilize miniaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in pancreatic tumors. We also deliver albumin directly into tumors using an implantable microdevice, which was adapted and modified from ref. 9. Following implantation, we directly observe protein catabolism and macropinocytosis in situ by pancreatic cancer cells, but not by adjacent, non-cancerous pancreatic tissue. In addition, we find that intratumoral inhibition of macropinocytosis decreases amino acid levels. Taken together, these data suggest that pancreatic cancer cells consume extracellular protein, including albumin, and that this consumption serves as an important source of amino acids for pancreatic cancer cells in vivo.
AB - Mammalian tissues rely on a variety of nutrients to support their physiological functions. It is known that altered metabolism is involved in the pathogenesis of cancer, but which nutrients support the inappropriate growth of intact malignant tumors is incompletely understood. Amino acids are essential nutrients for many cancer cells that can be obtained through the scavenging and catabolism of extracellular protein via macropinocytosis. In particular, macropinocytosis can be a nutrient source for pancreatic cancer cells, but it is not fully understood how the tumor environment influences metabolic phenotypes and whether macropinocytosis supports the maintenance of amino acid levels within pancreatic tumors. Here we utilize miniaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in pancreatic tumors. We also deliver albumin directly into tumors using an implantable microdevice, which was adapted and modified from ref. 9. Following implantation, we directly observe protein catabolism and macropinocytosis in situ by pancreatic cancer cells, but not by adjacent, non-cancerous pancreatic tissue. In addition, we find that intratumoral inhibition of macropinocytosis decreases amino acid levels. Taken together, these data suggest that pancreatic cancer cells consume extracellular protein, including albumin, and that this consumption serves as an important source of amino acids for pancreatic cancer cells in vivo.
UR - http://www.scopus.com/inward/record.url?scp=85007035398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007035398&partnerID=8YFLogxK
U2 - 10.1038/nm.4256
DO - 10.1038/nm.4256
M3 - Article
C2 - 28024083
AN - SCOPUS:85007035398
SN - 1078-8956
VL - 23
SP - 235
EP - 241
JO - Nature Medicine
JF - Nature Medicine
IS - 2
ER -